From: Predictors of COVID-19 vaccine uptake: an online three-wave survey study of US adults
 |  | Overall (n = 930) | Veteran (n = 584) | Non-Veteran (n = 346) | |
---|---|---|---|---|---|
Age in yrs – no. (%) |  |  | |||
 | 18 to 34 |  | 37 (4) | 0 (0) | 37 (11) |
 | 35 to 54 |  | 87 (9) | 16 (3) | 71 (21) |
 | 55 to 74 |  | 591 (64) | 390 (67) | 201 (58) |
 | 75 or older |  | 213 (23) | 176 (30) | 37 (10) |
 | Did not respond |  | 2 (< 1) | 2 (< 1) | 0 (0) |
Gender – n (%) |  |  |  |  | |
 | Female |  | 193 (21) | 38 (7) | 155 (45) |
 | Male |  | 735 (79) | 545 (93) | 190 (55) |
 | Non-binary/Third gender or Transgender man/Transman |  | 2 (< 1) | 1 (< 1) | 1 (< 1) |
Race/Ethnicity – no. (%) |  |  |  |  | |
 | Non-Hispanic White |  | 720 (77) | 447 (77) | 273 (79) |
 | Non-Hispanic Black |  | 64 (7) | 44 (8) | 20 (6) |
 | Hispanic |  | 92 (10) | 61 (10) | 31 (9) |
 | Asian/Asian American |  | 26 (3) | 9 (2) | 17 (5) |
 | American Indian/Alaskan Native |  | 4 (< 1) | 4 (1) | 0 (0) |
 | Native Hawaiian/Other Pacific Islander |  | 2 (< 1) | 2 (< 1) | 0 (0) |
 | Another race |  | 14 (2) | 11 (2) | 3 (1) |
 | Multiracial |  | 8 (1) | 6 (1) | 2 (1) |
Income – no. (%) |  |  |  |  | |
 | $0 - $49k |  | 206 (22) | 117 (20) | 89 (26) |
 | $50K to $99K |  | 362 (39) | 232 (40) | 130 (38) |
 | $100K or more |  | 325 (35) | 216 (37) | 109 (32) |
 | Prefer not to say |  | 37 (4) | 19 (3) | 18 (5) |
Residence – no. (%) |  |  |  |  | |
 | Rural |  | 151 (16) | 96 (16) | 55 (16) |
 | Small city (< 100,000) |  | 159 (17) | 101 (17) | 58 (17) |
 | Suburban, near a large city |  | 457 (49) | 277 (47) | 180 (52) |
 | Mid-sized city (100,000–1 million) |  | 90 (10) | 60 (10) | 30 (9) |
 | large city (> 1 million) |  | 70 (8) | 47 (8) | 23 (7) |
 | Other |  | 3 (< 1) | 3 (1) | 0 (0) |
Vaccination status in January 2021 – no. (%) |  |  |  |  | |
 | None |  | 765 (82) | 463 (79) | 302 (87) |
 | One dose |  | 160 (17) | 118 (20) | 42 (12) |
 | Two doses |  | 5 (1) | 3 (1) | 2 (1) |
Vaccination status in March 2021 – no. (%) |  |  |  |  | |
 | None (March) |  | 310 (33) | 146 (25) | 164 (47) |
 | One dose (March) |  | 206 (22) | 128 (22) | 78 (23) |
 | Two doses (March) |  | 414 (45) | 310 (53) | 104 (30) |